Funds a major constraint in implementing Cartagena Protocol
Parties to the protocol emphasise on need for capacity building for managing risks from genetically engineered products
Decision on capacity building to handle GMOs tops biosafety meet agenda
Countries have reported they lack appropriate legal, institutional and technical capacity for decision making on genetically modified organisms
Implementation of biosafety norms not satisfactory: Gbedemah
Funds availability a major hindrance, says head of biosafety at CBD